Amgen's PCSK9 Patent Battle: Legal Loss but Commercial Victory
In 2014, Amgen sued Sanofi and Regeneron to claim ownership of an entire class of cholesterol drugs. Nine years later, the Supreme Court ruled against them - but they won where it mattered most.
